Trial Identifier: | 2693-CL-0305 |
Sponsor: | Astellas Pharma China, Inc. |
Start Date: | March 2020 |
Primary Completion Date: | April 2022 |
Study Completion Date: | April 2022 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |